Measles in Texas: Austin doctor speaks on recent virus outbreak
The Brief
West Texas continues to deal with a measles outbreak
Now, Austin has confirmed its first case of the virus
An Austin doctor spoke about the recent outbreak
AUSTIN, Texas - West Texas continues to deal with a measles outbreak.
State health officials say, since January, 146 people, mostly children, have been infected across nine counties. More than 20 people in Texas have been hospitalized, and all of them are unvaccinated.
RELATED:Unvaccinated infant in Austin tests positive for virus
Also, this week, the state confirmed a young unvaccinated child died while being treated at a hospital in Lubbock. It is the first measles death in the U.S. in 10 years.
Dr. Elizabeth Douglass, an infectious disease expert and assistant professor of internal medicine at Dell Medical School at UT Austin, joined FOX 7 Austin's Rebecca Thomas to discuss.
Local perspective
Rebecca Thomas: Dr. Douglass, for those who don't know what measles is, and what are the symptoms?
Elizabeth Douglass, MD: So measles is a very highly contagious respiratory virus which affects if you're unvaccinated, 90% of individuals would be ill. Typically the symptoms range from they begin with a fever, headache, runny nose and then the patient develops a rash. Sometimes it could be a mild illness, but often it can be complicated as well, depending on the health status of the patient or even patients that do have a normal immune system. Some patients can get pneumonia. Some patients can have a brain infection. And there are various complications of measles.
Rebecca Thomas: Well, there is concern here in central Texas after an infected person from West Texas visited San Marcos and New Braunfels around Valentine's Day. What is the incubation period and how long does someone remain contagious?
Elizabeth Douglass, MD: So the incubation ranges from about 6 to 21 days. And a patient is contagious for 4 to 5 days before they have symptoms. And then up to four days after they have the rash. So there's a pretty long period.
Rebecca Thomas: Now, the CDC says two doses of the measles vaccine is 97% effective. How contagious, again, is measles if someone isn't vaccinated, and they're exposed to it?
Elizabeth Douglass, MD: So nine out of ten people will get sick. So it's highly contagious.
Rebecca Thomas: If you were vaccinated as a child, do you need a booster as an adult?
Elizabeth Douglass, MD: Now, if you received the two recommended vaccines, it's felt that you have lifelong immunity. There have been cases of measles in patients that are vaccinated, but they tend to be extremely mild. So at this point, it is not recommended that the general population get boosters.
Rebecca Thomas: From my understanding, if you were born prior to 1957, you were probably exposed to the measles, probably had it. But there was also a period in the 60s where the vaccine was not effective. Do you want to talk about that?
Elizabeth Douglass, MD: Yeah. They used to use a different vaccine. It was a killed vaccine, and it may not have been as effective. Patients that get sick with measles that had that vaccine, still get sick. It's a little bit different. They call it a typical measles infection. So, if you did not receive the two current vaccines two doses, it would be recommended that you receive another MMR vaccine.
Rebecca Thomas: If you do come down with measles, how is it typically treated?
Elizabeth Douglass, MD: So most of the treatment is completely supportive. There are rare cases where people, especially in children, very young children that have severe pneumonia, may be treated with an antiviral. But that's not the standard of care. It's usually supportive treatment. There's other rare instances where we give intravenous immunoglobulin, but generally it's supportive, which means just like when you have a cold, you just treat the symptoms.
Rebecca Thomas: How concerned are you that this current measles outbreak is going to expand further?
Elizabeth Douglass, MD: I am concerned. And hopefully, this will prompt individuals that are not vaccinated, or even if you're not sure that you're vaccinated to, at least in this period, receive another vaccine. There's no harm in getting an extra vaccine.
Rebecca Thomas: All right. Dr. Elizabeth Douglass with Dell Medical School at UT Austin, thank you so much for sharing your time and your expertise with us tonight.
The Source
Information from an interview conducted by FOX 7 Austin's Rebecca Thomas
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Virginia Beach school raises thousands for Operation Smile
VIRGINIA BEACH, Va. (WAVY) – Old Donation School in Virginia Beach has raised thousands of dollars to support a local organization that is changing lives around the world. Now, the school forever has a symbol of its hard work and dedication to the cause. 'This is what I like to call it a passion project,' said Lizzie Meyers, a fourth-grade teacher at ODS. 'This has been a long time coming.' Several years ago, Meyers created a club at the school to teach children about , which is based in Virginia Beach. 'They understand that the whole platform of Operation Smile is to improve lives of our children around the world who have [a] cleft palate and need the surgeries and don't have the means to do it themselves,' Meyers said. That brings us to . ODS held multiple fundraisers earning $6,000 to have a dolphin statue placed in their school. Meyers said the Operation Smile Club at ODS let students and staff know they wanted to earn the statue, but they needed the help of everyone, and everyone stepped up. 'We started fundraising early in the year,' Meyers said. 'Candy grams are a huge hit at our school. So, we did candy grams for Halloween, and then we did candy grams again right around winter break. Then, we had the highlight of their year, which is the middle school dance. We did candy grams again for Valentine's Day. So, candy crahams are a big hit.' Funds raised go to programs at Operation Smile to provide leadership training for Hampton Roads students and to help with the costs of surgery for people born around the world with cleft palate conditions. Over the last three years, the Operation Smile Club at ODS has raised more than $14,000 for the organization. 'In years past. we've always done fundraising to just give to Operation Smile, and their goal has always been to try to beat the year before,' Meyers said. 'So, they know that a surgery is around $250. So they always try to breakdown our donation to see how many surgeries, and then we have morning announcements every morning, and that's a big highlight. They like to be able to tell everyone as a community we came together and we helped make this difference, so we can be proud of the fact that we earned this many surgeries this year.' ODS seventh grader Peyton Smith won her school's design competition for the dolphin. 'It's just something that's really special to me,' Peyton said. 'We got an opportunity that we were able to design for Operation Smile how we could picture it in our mind and have it come to life, and for me, I feel like the ocean and the beach is like my house, and I feel like everyone at ODS should feel welcome in their own home, and you should be [at] a place where everyone feels comfortable. It's like a good learning environment, and since we represent, like, rising tide at each grade level, we have a different team of animals and stuff like that, I really thought that Virginia Beach should be represented by a home, like the beach. That was my inspiration.' The details painted on the dolphin are vibrant. The mission is life changing, and ODS now, and forever, has a symbol of the difference the school community has made. 'We have been told that we are the first elementary and middle school, public school, in Virginia Beach to earn the dolphin statue,' Meyers said. 'So we're very proud of that.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
New York Times
a day ago
- New York Times
I Think My Son Is Gay. Should I Talk to Him About Coming Out?
I am the mother of two delightful teenage boys in the throes of navigating all the challenges that youth brings. Over the past few years, it has become evident to me that my younger son is most likely gay. I believe I am the only person in the family to have noticed his interest in rainbow flags or his outrage at injustices to the L.G.B.T.Q.+ community, among other, subtler, indications. I've always thought it quite unfair that only those who fall under the L.G.B.T.Q.+ umbrella have the onerous burden of 'coming out.' Last summer my son weathered the heartbreak of a dear friend, likely a crush, moving away. For Valentine's Day, a female classmate asked my son out, and he turned her down. His life is getting increasingly complicated. I don't want to push him to come out before he's ready, but I'd love to be able to have honest conversations about some of what he's going through. My question is: Should I wait and let him come out when he's ready, or is there a way I can save him the trouble? What is the most thoughtful way to approach this? — Name Withheld From the Ethicist: I get why you want to spare him the awkward dance of coming out, but for many young people, it's a way to claim an identity on their terms. (For many parents, in turn, it involves pretending that the declaration comes as news.) Pressing fast-forward could leave him with the sense that he has lost a measure of agency — that a big moment has been pre-empted. It could also make him feel exposed or rushed. There are all sorts of ways that you can indicate your loving acceptance and reassure him that you'll be a soft place to land. Indeed, I'm sure you've already done so. When he's ready, you'll be there — arms open, heart steady, no script needed. Readers Respond The previous question was from a reader wondering whether to disclose the toxic products used on the shared lawn when selling a condo. The reader wrote: 'I am hoping to sell my condo. I live in a homeowner's association that still uses many toxic landscaping products. … Several residents have worked over the past two years, without success, to change the association's landscaping practices. What is my obligation to disclose these harmful products to prospective buyers, especially those with young children and pets?' Want all of The Times? Subscribe.
Yahoo
2 days ago
- Yahoo
Emerging Markets Report: Shedding Some Light
A Recent Update from Light AI Gives Readers a Road Map for the Future An Emerging Markets Sponsored Commentary ORLANDO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- While there are no crystal balls in modern financial markets there are the words of those who know more, who share from the inside out the state of affairs inside a public company and speak to its future. One would think the word 'public' in the descriptor for traded company would compel such disclosures, more transmissions to the markets about what's happening and bold dreams for the moments to come. Sadly, such missives are more rare than what we as watchers of the market would like to see making a recent press release from Light AI Inc. (OTCQB: OHCFF) (CBOE CA: ALGO) (FSE: 0HC) a global healthcare technology company focused on developing artificial intelligence health diagnostic and wellness solutions, a most welcomed offering. But you see, this welcome news is made more interesting because, well, the Company is more interesting than most as it is positioned at the intersection of two rapidly expanding markets, Healthcare and Artificial Intelligence (AI). Both industries are forecast to enjoy rapid expansion, Healthcare driven primarily be an aging population, and AI, well, because it seems as if it just might be used in nearly every industry in some form or fashion in the days and decades to come. If you don't believe this to be true, cut bait now and go look for that aforementioned crystal ball. If you concur as we do then spend a couple paragraphs to find out a little more about Light AI and what it just told the market. In a release just before Valentine's Day, Light AI posted a business update that essentially takes us inside the boardroom, on the white board, and maybe, a just a little bit inside the CEO's head. It's chock full of good news, the Company's critical AI mature algorithm is exceeding expectations, so much so that the process integrating into professional and wellness vertical has been expedited. For us, that sure sounds like it could be a path to potential revenue. The Company also points to product validation efforts that suggest a mindfulness in their offering. French author Voltaire famously said, 'With great power comes great responsibility,' which might well be the front bumper sticker for an AI industry that many view with dual quantums of enthusiasm and caution. But quite notably, the report ends with an update on the Company's efforts on the African continent. A cut and paste is warranted: The Company anticipates partnering with Tech Care For All ('TC4A') to roll out the Company's platform to the LMIC market, initially focusing on Africa. TC4A is a social impact company whose goal is to accelerate digital health in Africa and Asia to improve health outcomes in underserved communities. TC4A developed and operates a global medical learning platform targeting healthcare professionals in LMIC markets. This partnership will allow the Company platform to be introduced as a screening tool in markets that do not require the FDA approval, enabling the Company to seek a path to near-term revenue. The first phase of the project involves conducting a pilot go-to-market study to assess the clinical efficacy, clinical pathways, use cases, economics, reimbursement and subscription models and cloud infrastructure needs and deployment strategies in four initial countries – Kenya, Uganda, Nigeria and South Africa, with a plan to subsequently roll out the technology in such countries. Assuming the successful conclusion of the first phase market study, the Company's intention is to use the results of the pilot study to design go-to market strategies and roll out the technology in 16 additional African countries. Assuming the successful conclusion of the second phase roll out, the Company's intention would be to launch a diagnostic offering, through global distributions partners, based on the technology in these countries following receipt of required regulatory approvals. The Company anticipates that smartphones will be supplied to practitioners by TC4A agents on behalf of the Company. Following the completion of the market landscape analysis in Africa, the Company and TC4A are exploring a similar analysis for the Indian market, with the potential for TC4A to manage licensing and regulations on a country-by-country basis. Timely detection of GAS at the point of care has the potential to generate material financial savings for healthcare payers. Implementing the Company's smartphone-based tool for GAS in Africa and LMIC markets could yield a substantial dollar saving by reducing the need for in-clinic testing and minimizing the expensive treatment costs associated with untreated cases. Additionally, early intervention can prevent indirect costs related to productivity losses, estimated to be a significant economic strain on families, who often rely on income from daily work to meet essential needs. First off, we love that the Company is looking to bring high tech health care innovation to a continent too often ignored by the most avant garde of technology. And we love the scale that Africa presents and that the release uses the phrase 'across Africa' to describe the opportunity. Updates about Light AI's African efforts will be most welcomed. All-in-all, the update is an impressive assemblage of good news for the Company and a reason to keep their news feed on the proverbial radar. About The Emerging Markets Report: The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at: Must Read OTC Markets/SEC policy on stock promotion and investor protection Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. EMC has been paid $150,000 by Light AI Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. Forward-Looking Statements This article contains forward-looking statements about Light AI Inc., which are identified by terms such as "anticipate," "expect," and "project." These statements reflect current views regarding company performance, business goals, healthcare market expectations, and intellectual property development. The statements are based on current business and market expectations. However, they involve various risks and uncertainties, including potential delays, financial difficulties, operational challenges, and problems protecting intellectual property. Additional risks include possible regulatory approval delays, market disruptions, personnel issues, and competitive pressures. Given these risks and uncertainties, actual results may differ significantly from what is described in the forward-looking statements. Readers should not place undue reliance on these statements, which are only valid as of the article's publication date and we undertake no obligation to update. For Media Inquiries, please contact Maggie Caraway: maggie@
